Drug‐Free Remission in Early Peripheral Spondyloarthritis, including Psoriatic Arthritis: 10‐year follow‐up from the CRESPA trial

Study limitation reported by the research below: “Sample size is small (n=49 at follow-up), limiting the reliability of subgroup comparisons and the OR estimate for drug-free remission in non-psoriatic pSpA.”